See more : Wall Financial Corporation (WFC.TO) Income Statement Analysis – Financial Results
Complete financial analysis of AptarGroup, Inc. (ATR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AptarGroup, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Tasty Concepts Holding Limited (8096.HK) Income Statement Analysis – Financial Results
- PB Fintech Limited (POLICYBZR.NS) Income Statement Analysis – Financial Results
- Chavant Capital Acquisition Corp. (CLAYW) Income Statement Analysis – Financial Results
- Fuller, Smith & Turner P.L.C. (53GW.L) Income Statement Analysis – Financial Results
- Sacks Parente Golf, Inc. (SPGC) Income Statement Analysis – Financial Results
AptarGroup, Inc. (ATR)
About AptarGroup, Inc.
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.49B | 3.32B | 3.23B | 2.93B | 2.86B | 2.76B | 2.47B | 2.33B | 2.32B | 2.60B | 2.52B | 2.33B | 2.34B | 2.08B | 1.84B | 2.07B | 1.89B | 1.60B | 1.38B | 1.30B | 1.11B | 926.69M | 891.99M | 883.48M | 834.30M | 713.50M | 655.40M | 615.80M | 557.50M | 474.30M | 411.50M | 370.30M |
| Cost of Revenue | 2.22B | 2.16B | 2.07B | 1.84B | 1.82B | 1.81B | 1.60B | 1.50B | 1.50B | 1.76B | 1.71B | 1.59B | 1.57B | 1.38B | 1.23B | 1.41B | 1.28B | 1.09B | 927.59M | 866.87M | 732.04M | 593.72M | 562.81M | 553.64M | 519.70M | 444.60M | 418.10M | 399.70M | 358.40M | 301.50M | 262.50M | 244.90M |
| Gross Profit | 1.26B | 1.16B | 1.16B | 1.09B | 1.04B | 951.80M | 865.10M | 832.86M | 814.50M | 842.54M | 811.08M | 740.67M | 768.90M | 697.93M | 615.95M | 660.41M | 608.39M | 515.12M | 452.42M | 429.74M | 382.65M | 332.97M | 329.17M | 329.84M | 314.60M | 268.90M | 237.30M | 216.10M | 199.10M | 172.80M | 149.00M | 125.40M |
| Gross Profit Ratio | 36.23% | 35.03% | 35.84% | 37.09% | 36.41% | 34.43% | 35.03% | 35.73% | 35.15% | 32.43% | 32.19% | 31.77% | 32.90% | 33.61% | 33.45% | 31.88% | 32.15% | 32.17% | 32.78% | 33.14% | 34.33% | 35.93% | 36.90% | 37.33% | 37.71% | 37.69% | 36.21% | 35.09% | 35.71% | 36.43% | 36.21% | 33.86% |
| Research & Development | 565.78M | 544.26M | 551.24M | 92.50M | 82.80M | 75.30M | 68.20M | 66.20M | 67.10M | 76.20M | 71.80M | 65.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 429.96M | 388.28M | 367.56M | 351.46M | 383.91M | 364.75M | 341.63M | 347.63M | 296.86M | 276.99M | 300.85M | 274.20M | 238.91M | 203.39M | 194.37M | 171.60M | 148.35M | 146.14M | 145.00M | 137.50M | 119.30M | 108.40M | 104.30M | 96.20M | 85.70M | 75.80M | 63.30M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 565.78M | 544.26M | 551.24M | 500.23M | 454.62M | 429.96M | 388.28M | 367.56M | 351.46M | 383.91M | 364.75M | 341.63M | 347.63M | 296.86M | 276.99M | 300.85M | 274.20M | 238.91M | 203.39M | 194.37M | 171.60M | 148.35M | 146.14M | 145.00M | 137.50M | 119.30M | 108.40M | 104.30M | 96.20M | 85.70M | 75.80M | 63.30M |
| Other Expenses | 0.00 | -310.56M | 234.85M | 220.30M | 194.55M | 5.55M | 8.66M | 2.78M | 163.00K | -1.97M | -2.03M | -1.13M | 134.24M | 132.96M | 133.01M | 131.15M | 123.47M | 114.61M | 99.24M | 94.49M | 85.85M | 77.55M | 81.17M | 70.95M | 68.70M | 54.40M | 49.90M | 47.90M | 43.50M | 38.40M | 32.10M | 26.20M |
| Operating Expenses | 852.53M | 777.97M | 786.10M | 720.53M | 649.17M | 601.70M | 541.38M | 522.36M | 490.35M | 536.13M | 514.70M | 478.66M | 481.87M | 429.82M | 417.57M | 431.99M | 397.66M | 353.51M | 302.63M | 288.86M | 257.46M | 225.90M | 227.30M | 215.95M | 206.20M | 173.70M | 158.30M | 152.20M | 139.70M | 124.10M | 107.90M | 89.50M |
| Cost & Expenses | 3.08B | 2.94B | 2.86B | 2.56B | 2.47B | 2.41B | 2.15B | 2.02B | 1.99B | 2.29B | 2.22B | 2.07B | 2.05B | 1.81B | 1.64B | 1.84B | 1.68B | 1.44B | 1.23B | 1.16B | 989.49M | 819.62M | 790.12M | 769.59M | 725.90M | 618.30M | 576.40M | 551.90M | 498.10M | 425.60M | 370.40M | 334.40M |
| Interest Income | 4.37M | 2.70M | 3.67M | 958.00K | 4.17M | 7.06M | 5.47M | 2.64M | 5.60M | 4.80M | 3.23M | 3.00M | 5.72M | 3.25M | 3.33M | 13.12M | 8.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 40.42M | 40.83M | 30.28M | 33.24M | 35.49M | 32.63M | 40.60M | 35.24M | 34.62M | 21.03M | 20.51M | 18.95M | 17.30M | 14.37M | 16.49M | 18.69M | 19.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 248.59M | 233.71M | 234.85M | 220.30M | 194.55M | 171.75M | 153.09M | 154.80M | 138.89M | 152.22M | 149.96M | 137.02M | 134.24M | 132.96M | 133.01M | 131.15M | 123.47M | 114.61M | 99.24M | 94.49M | 85.85M | 72.14M | 73.58M | 70.95M | 68.70M | 54.40M | 49.90M | 47.90M | 43.50M | 38.40M | 32.10M | 26.20M |
| EBITDA | 663.84M | 609.41M | 586.79M | 556.17M | 576.92M | 475.57M | 490.08M | 470.50M | 468.04M | 459.51M | 446.65M | 397.35M | 426.49M | 401.72M | 333.56M | 370.81M | 342.92M | 276.21M | 249.04M | 235.38M | 209.80M | 179.21M | 175.45M | 184.84M | 177.14M | 149.60M | 128.90M | 111.80M | 102.90M | 87.10M | 73.20M | 62.10M |
| EBITDA Ratio | 19.03% | 18.60% | 18.76% | 19.84% | 20.72% | 19.32% | 19.87% | 20.19% | 20.20% | 17.69% | 17.72% | 17.18% | 18.27% | 19.47% | 18.18% | 17.90% | 17.70% | 17.31% | 18.10% | 18.07% | 19.09% | 19.97% | 20.40% | 20.69% | 21.63% | 19.44% | 18.87% | 17.70% | 17.69% | 17.79% | 16.65% | 15.50% |
| Operating Income | 404.02M | 379.27M | 347.35M | 339.50M | 371.69M | 286.27M | 321.52M | 310.50M | 324.15M | 306.42M | 284.57M | 258.91M | 287.03M | 268.11M | 205.94M | 228.42M | 210.73M | 161.60M | 149.79M | 140.88M | 125.20M | 107.07M | 101.87M | 113.89M | 108.40M | 95.20M | 79.00M | 63.90M | 59.40M | 48.70M | 41.10M | 35.90M |
| Operating Income Ratio | 11.58% | 11.42% | 10.76% | 11.59% | 13.00% | 10.35% | 13.02% | 13.32% | 13.99% | 11.80% | 11.29% | 11.11% | 12.28% | 12.91% | 11.18% | 11.03% | 11.14% | 10.09% | 10.85% | 10.87% | 11.23% | 11.55% | 11.42% | 12.89% | 12.99% | 13.34% | 12.05% | 10.38% | 10.65% | 10.27% | 9.99% | 9.69% |
| Total Other Income/Expenses | -29.19M | -44.57M | -47.03M | -38.34M | -29.62M | -20.25M | -28.66M | -35.60M | -29.57M | -20.12M | -34.72M | -17.54M | -12.08M | -13.72M | -21.89M | -7.45M | -10.74M | -13.30M | -7.84M | -3.71M | -6.68M | -8.72M | -13.51M | -15.97M | -16.64M | 4.00M | -400.00K | -3.80M | -1.80M | -5.30M | -6.30M | -4.90M |
| Income Before Tax | 374.83M | 334.70M | 321.66M | 301.16M | 342.07M | 266.02M | 294.83M | 280.50M | 294.57M | 286.30M | 264.38M | 241.37M | 274.94M | 254.39M | 184.06M | 220.97M | 200.00M | 148.31M | 141.95M | 137.18M | 117.27M | 98.36M | 88.36M | 97.92M | 91.80M | 99.20M | 78.60M | 60.10M | 57.60M | 43.40M | 34.80M | 31.00M |
| Income Before Tax Ratio | 10.75% | 10.07% | 9.97% | 10.28% | 11.96% | 9.62% | 11.94% | 12.03% | 12.71% | 11.02% | 10.49% | 10.35% | 11.76% | 12.25% | 9.99% | 10.67% | 10.57% | 9.26% | 10.29% | 10.58% | 10.52% | 10.61% | 9.91% | 11.08% | 11.00% | 13.90% | 11.99% | 9.76% | 10.33% | 9.15% | 8.46% | 8.37% |
| Income Tax Expense | 90.65M | 95.15M | 78.02M | 87.07M | 99.84M | 71.25M | 74.80M | 74.89M | 95.28M | 94.68M | 92.46M | 78.95M | 91.31M | 80.80M | 59.46M | 67.47M | 60.49M | 45.41M | 41.92M | 43.89M | 37.59M | 31.71M | 29.45M | 33.26M | 33.10M | 38.40M | 32.10M | 22.60M | 21.90M | 16.10M | 13.20M | 11.50M |
| Net Income | 284.49M | 239.29M | 244.10M | 214.04M | 242.20M | 194.75M | 220.03M | 205.59M | 199.35M | 191.66M | 171.99M | 162.61M | 183.68M | 173.48M | 124.62M | 153.50M | 141.74M | 102.90M | 100.03M | 93.29M | 79.68M | 66.65M | 58.84M | 64.67M | 58.70M | 60.80M | 46.50M | 37.50M | 35.70M | 27.30M | 23.00M | 19.50M |
| Net Income Ratio | 8.16% | 7.20% | 7.56% | 7.31% | 8.47% | 7.04% | 8.91% | 8.82% | 8.60% | 7.38% | 6.83% | 6.98% | 7.86% | 8.35% | 6.77% | 7.41% | 7.49% | 6.43% | 7.25% | 7.19% | 7.15% | 7.19% | 6.60% | 7.32% | 7.04% | 8.52% | 7.09% | 6.09% | 6.40% | 5.76% | 5.59% | 5.27% |
| EPS | 4.34 | 3.66 | 3.72 | 3.32 | 3.81 | 3.12 | 3.52 | 3.27 | 3.19 | 2.95 | 2.60 | 2.45 | 2.76 | 2.58 | 1.84 | 2.26 | 2.06 | 1.48 | 1.42 | 1.29 | 1.11 | 0.93 | 0.82 | 0.90 | 0.81 | 0.85 | 0.65 | 0.52 | 0.50 | 0.42 | 0.36 | 0.30 |
| EPS Diluted | 4.25 | 3.59 | 3.60 | 3.21 | 3.66 | 3.00 | 3.41 | 3.17 | 3.09 | 2.85 | 2.52 | 2.38 | 2.65 | 2.48 | 1.79 | 2.18 | 1.98 | 1.44 | 1.39 | 1.25 | 1.08 | 0.91 | 0.81 | 0.89 | 0.80 | 0.83 | 0.64 | 0.52 | 0.50 | 0.42 | 0.36 | 0.30 |
| Weighted Avg Shares Out | 65.62M | 65.40M | 65.66M | 64.42M | 63.57M | 62.44M | 62.44M | 62.80M | 62.59M | 65.01M | 66.09M | 66.39M | 66.55M | 67.34M | 67.64M | 67.85M | 68.77M | 69.76M | 70.45M | 72.32M | 72.11M | 71.66M | 71.76M | 71.85M | 72.47M | 71.95M | 71.81M | 71.77M | 71.40M | 65.78M | 63.89M | 66.10M |
| Weighted Avg Shares Out (Dil) | 66.91M | 66.72M | 67.68M | 66.66M | 66.15M | 64.96M | 64.60M | 64.85M | 64.49M | 67.29M | 68.21M | 68.40M | 69.27M | 69.82M | 69.79M | 70.52M | 71.52M | 71.70M | 72.23M | 74.33M | 73.78M | 73.24M | 73.10M | 72.66M | 73.84M | 73.70M | 72.94M | 71.77M | 72.12M | 65.78M | 63.89M | 66.10M |
BERY or ATR: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Berry Global (BERY) and AptarGroup (ATR). But which of these two companies is the best option for those looking for undervalued stocks?
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices.
Here's Why Momentum in AptarGroup (ATR) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, AptarGroup (ATR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
ATR Expands “Renewed in America” Electronics on Amazon: A Call to Action for Sustainable Living and Local Job Creation
PENSACOLA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Advanced Technology Recycling (ATR), a national leader in sustainable electronics recycling and IT asset management, is proud to announce the expansion of our “Renewed in America” product line on Amazon Marketplaces.
SON or ATR: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Sonoco (SON) and AptarGroup (ATR). But which of these two stocks is more attractive to value investors?
4 Containers - Paper and Packaging Stocks to Buy in a Promising Industry
E-commerce and consumer demand will drive the Zacks Containers-Paper & Packaging industry. Stocks like PKG, BXBLY, ATR and GEF are solid picks for investors.
AptarGroup Hits 52-Week High: What's Driving the Stock's Performance?
The ATR stock gains from the increased demand in the Pharma segment and its strategic actions.
Is AptarGroup (ATR) Stock Outpacing Its Industrial Products Peers This Year?
Here is how AptarGroup (ATR) and Century Aluminum (CENX) have performed compared to their sector so far this year.
AptarGroup (ATR) Earnings Beat Estimates in Q2, Increase Y/Y
AptarGroup's (ATR) Q2 top line increases y/y, driven by the strong performance in the Pharma segment.
Source: https://incomestatements.info
Category: Stock Reports